We found that p38i (SB203580) was still able to enhance IL-12 and suppress IL-10 in advanced cancer patients (Fig. 5a, p = 0.0015 for IL-12, p = 0.0025 for IL-10) without affecting other cytokines (not shown). The gene discussed is IL10; the disease is cancer.